Literature DB >> 16049165

Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy.

Kathryn E Greenwood1, Sabine Landau, Til Wykes.   

Abstract

Negative symptoms and poor cognition are both associated with poor functional outcome in schizophrenia. This poor functional outcome has been attributed to poor cognition rather than any independent contribution from symptoms. Identifying target cognitive processes and mechanisms that predict community function, and possible moderator effects of negative symptoms, will allow the development of cognitive remediation programs that are successful in improving functional outcome. A referred sample of 53 in- and outpatients with schizophrenia with general cognitive impairment (including 28 with severe negative symptoms) and 22 healthy controls, balanced for premorbid IQ, were compared cross sectionally on measures of community shopping skills, executive function, and working memory. Across the groups, there were direct relationships between community functioning and specific executive functions, and there were interactions between group membership and the types of associations found. Working memory was independently associated with accurate community functioning only in people with schizophrenia and negative symptoms. This association was not due to the sole presence of working memory impairment or just to negative symptoms. Poor community function is predicted both by specific cognitive impairments that are prominent in people with negative symptoms and through the moderating effect of negative symptoms on the working memory-community function relationship. This may reflect a synergistic association between symptoms and cognition: negative symptoms arise from cognitive impairment but also impact detrimentally on working memory functioning. Both cognitive processes and negative symptoms should be targeted in cognitive remediation to effect the greatest change in community functions.

Entities:  

Mesh:

Year:  2005        PMID: 16049165     DOI: 10.1093/schbul/sbi035

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  24 in total

1.  Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.

Authors:  Robert W Buchanan; Elaine Weiner; Deanna L Kelly; James M Gold; William R Keller; James A Waltz; Robert P McMahon; David A Gorelick
Journal:  Schizophr Bull       Date:  2014-11-02       Impact factor: 9.306

2.  Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia.

Authors:  O Puig; R Penadés; I Baeza; V Sánchez-Gistau; E De la Serna; L Fonrodona; S Andrés-Perpiñá; M Bernardo; J Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

Review 3.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

Review 4.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

5.  Frontal slow-wave activity as a predictor of negative symptoms, cognition and functional capacity in schizophrenia.

Authors:  Yu-Han Chen; Breannan Stone-Howell; J Christopher Edgar; Mingxiong Huang; Cassandra Wootton; Michael A Hunter; Brett Y Lu; Joseph R Sadek; Gregory A Miller; José M Cañive
Journal:  Br J Psychiatry       Date:  2015-07-23       Impact factor: 9.319

6.  William T. Carpenter Jr: 35 years of clinical trials.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

7.  Impaired error-likelihood prediction in medial prefrontal cortex in schizophrenia.

Authors:  Adam Krawitz; Todd S Braver; Deanna M Barch; Joshua W Brown
Journal:  Neuroimage       Date:  2010-09-17       Impact factor: 6.556

8.  Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities.

Authors:  Silvana Galderisi; Giuseppe Piegari; Armida Mucci; Antonio Acerra; Lucio Luciano; Anna F Rabasca; Francesco Santucci; Angela Valente; Maurizio Volpe; Pasquale Mastantuono; Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-15       Impact factor: 5.270

Review 9.  Distinct conflict resolution deficits related to different facets of Schizophrenia.

Authors:  John G Kerns
Journal:  Psychol Res       Date:  2008-11-26

Review 10.  Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.

Authors:  Samantha E Yohn; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.